Sulfotyrosine Recognition as Marker for Druggable Sites in the Extracellular Space
Chemokine signaling is a well-known agent of autoimmune disease, HIV infection, and cancer. Drug discovery efforts for these signaling molecules have focused on developing inhibitors targeting their associated G protein-coupled receptors. Recently, we used a structure-based approach directed at the...
Main Authors: | Brian F. Volkman, Francis C. Peterson, Christopher T. Veldkamp, Maxime S. Heroux, Joshua J. Ziarek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/12/6/3740/ |
Similar Items
-
CCR7 Sulfotyrosine Enhances CCL21 Binding
by: Andrew J. Phillips, et al.
Published: (2017-08-01) -
Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands
by: Natasha A. Moussouras, et al.
Published: (2017-09-01) -
Synthesis of Sulfotyrosine Bearing Peptides and Analogues
by: Ali, Ahmed Magdy Ahmed Mohamed
Published: (2010) -
Synthesis of Sulfotyrosine Bearing Peptides and Analogues
by: Ali, Ahmed Magdy Ahmed Mohamed
Published: (2010) -
Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection
by: Aiden Eblimit, et al.
Published: (2021-09-01)